Get in touch

Holly Logue

Associate General Counsel Gilead Sciences; Private Company Board Member


Enterprise SaaS, healthcare, biotech, medical device, diagnostics, AI/ML, data science, environmental sustainability


Go to market, multiple product launches, regulatory (FDA, CMS), IPO readiness, M&A, integration, corporate development and complex transactions, governance, legal and HR operations, capital raises, finance, commercial growth.


pre-revenue to $20M, $10M to $100M, seed to late stage growth, small cap public company

Design by: